PCL vs HA Filler: How to Choose
One of these injectables adds volume with a gel that is gradually absorbed and can be dissolved if something goes wrong. The other leaves a scaffold in the tissue that asks the skin to build collagen, and it cannot be dissolved by anything. That single difference decides more of this choice than onset, cost or how long the result lasts, and this site sets it out plainly.
Reviewed by Ke He, MD, head of skin and laser aesthetics at Chongqing West District Hospital. Neither injectable is a default. Hyaluronic acid filler is temporary and dissolvable; polycaprolactone is not dissolvable and its result develops over months. No result is guaranteed.
Start with what cannot be undone
Most comparisons of these two materials begin with how quickly each works or how long each lasts. Those are real differences, and they are not the ones that decide the choice for most people. The first question is what you would do if you disliked the result. Hyaluronic acid filler can be dissolved with an enzyme, which is a property of that substance class and not a marketing claim. Polycaprolactone cannot be dissolved by anything. If an uneven area, an over-treated region or a nodule develops, one of these materials offers an exit and the other does not. The second question is what the material leaves in your tissue. One is a gel that occupies space and is gradually absorbed; the other is a scaffold that remains while the skin builds collagen around it, so the result develops over months rather than at the appointment. The third question is what the problem actually is. Neither material repositions descended tissue or replaces the fat that has been lost across a whole face. Where the finding is descent, both are the wrong answer. Naming which of the three questions you are actually asking is the assessment.
What each one changes, and where each one stops
One adds volume and is absorbed. One adds volume and leaves a scaffold behind. Neither repositions anything.
Hyaluronic acid filler adds volume
A gel is placed into the tissue and occupies space, so the volume is there when the swelling settles. It is gradually absorbed over months, which is why the result fades and why repeat treatment is the normal expectation rather than a failure. It can be dissolved with an enzyme if a result is wrong or a complication needs addressing.
Polycaprolactone fills now and prompts collagen after
Some volume is present immediately, and the material remains in the tissue as a scaffold while the skin builds collagen around it over the following months. That is why the result is judged months after treatment rather than at the appointment, and why judging it on the day misreads it in both directions.
What neither one repositions
Neither lifts tissue that has descended. A jawline that has dropped, a cheek that no longer sits where it did and a neck that has loosened are position problems, and adding volume to a face that has dropped produces a heavier version of the same shape rather than a raised one. This is the single commonest mismatch in injectable practice.
What neither one restores
Neither replaces the fat that has been lost across a whole face, and neither changes skin quality. Texture, pigment and sun damage are properties of the surface. Where a face has lost volume generally rather than in one place, the question is a different one, and it is worth asking whether repeated injections are the right way to answer it.
Polycaprolactone cannot be dissolved
This is the difference the reader must not miss. There is no dissolving agent for this material. An uneven area, an over-treated region or a nodule cannot be removed by injection; it is managed, watched, or in some cases removed surgically. That does not make the material wrong, and it does mean the decision is heavier and that the assessment matters more.
Hyaluronic acid dissolves, but not cleanly
Dissolving is not an undo button. It is not always complete, it may take more than one session, and the enzyme carries its own risks, including the breakdown of the patient's own hyaluronic acid in the treated area and, rarely, an allergic reaction. It is a real exit and it is not a perfect one, and a patient should not choose the material on the assumption that dissolving is effortless.
What each recovery asks of your calendar
Neither is an operation and neither keeps you at home, and the days afterwards differ in character. Hyaluronic acid filler produces swelling and bruising at the injection sites, which usually settle over several days; the result is visible once the swelling has gone, and there is usually no time off work. Polycaprolactone produces swelling and firmness rather than bruising alone, and the firmness can persist for days and sometimes longer as the tissue responds. There is a second difference that matters more than either. The result of a hyaluronic acid filler is judged within days of the swelling settling; the result of polycaprolactone is judged over months, because a large part of it is the collagen the skin builds afterwards. A patient who needs to know what they look like before an event is choosing between these two materials on that basis, and it is a legitimate basis. Both come with advice afterwards about heat, exercise and pressure on the treated area, and both expect you to report anything that seems wrong rather than wait for the next appointment.
How long each one holds, without a promise either way
These two materials hold for different reasons, which is why the comparison is not a simple matter of one lasting longer than the other. Hyaluronic acid filler is absorbed over a period measured in months, depending on the product, the area and the individual. That is not a defect; it is what makes the treatment repeatable and the exit available. Polycaprolactone remains in the tissue as a scaffold and the collagen built around it persists, so the change commonly lasts longer and fades gradually rather than ending. How much longer cannot be promised for you: the response varies between individuals, the area treated matters, and how the skin behaves over the following months is part of the result. What can be said fairly is that one material asks you to return on a calendar and the other asks you to accept a result you cannot undo. Neither is a permanent answer, and neither stops the face from continuing to age.
The risks of each, stated at the same volume
Both are injections into the face, so both share the risks of any injectable. Bruising and swelling are expected. Lumps and unevenness are possible with either material, and are usually the result of placement rather than of the material itself. Infection is uncommon and serious when it happens. And both carry the risk that overshadows the rest: material entering a blood vessel and blocking the supply to skin and, in the worst cases, to the eye. That is a time-critical emergency requiring immediate care rather than an appointment next week, and it is the reason injectables belong in a setting with a plan for it. Beyond the shared list, the two differ. Hyaluronic acid filler carries the risk of an allergic reaction and the risks of dissolving it. Polycaprolactone carries nodules and firm areas, which can appear months after treatment rather than immediately, and which cannot be dissolved. It also carries the risk that the collagen response is uneven, so that one area builds more than another. Neither list is shorter than the other in any meaningful sense. They are different risks, and one of them is permanent.
What can be undone, and what cannot
This is the clearest genuine difference between the two materials and it runs in one direction only. Hyaluronic acid filler can be dissolved with an enzyme. If a result is wrong, if an area is over-treated, or if a complication needs addressing, there is an intervention that breaks the product down. It is not a clean undo: dissolving is not always complete, it may need more than one session, and the enzyme carries its own risks, including breaking down the patient's own hyaluronic acid in the treated area and, rarely, an allergic reaction. Polycaprolactone cannot be dissolved. There is no agent that removes it, and no injection that reverses the collagen response it provoked. A nodule or an uneven area is managed, watched, or in some cases removed surgically; it is not dissolved. A patient choosing this material is choosing an outcome they will live with, and that is a legitimate choice when it is made knowingly and when the assessment has been thorough. What it is not is a choice that can be revised afterwards, and the difference between the two columns on this row is the single most important thing on the page.
What actually drives the cost of each
This site quotes no figure and no range, because a number on a website is not a quotation for your face. The drivers are what matter. On both sides the total is driven by how much material a given area requires, which follows from the area and from what the assessment found rather than from a fixed quantity; by how many areas are treated; by who performs the treatment and in what setting; and by the follow-up, which matters more with an irreversible material because the review points are part of the treatment rather than a courtesy. Where the two part company is in what you are buying. A hyaluronic acid filler is a purchase that repeats, so the honest total is the cost of maintaining the result across several years. Polycaprolactone is closer to a single decision whose result fades slowly, so the total is concentrated earlier and the question becomes what happens if the result is not what you wanted, since correcting it is not a matter of dissolving it. Comparing one appointment with one appointment tells you very little about either.
PCL biostimulator and HA filler, side by side
Two columns of the same width, every row a plain fact about one material beside a plain fact about the other. Neither column is set apart, because neither material is the default. One of these rows decides more of the choice than the rest.
The comparison, in eight guides
One guide per question a patient actually faces: what each material leaves in the tissue, the two-phase result of a biostimulator, what the first months feel like, how placement differs, nodules, repeat cycles, the assessment before an irreversible material, and the cases where neither injectable adds what is missing.
PCL Or HA Filler: A Scaffold Or A Gel
A gel that occupies space and is absorbed, or a scaffold that stays while the skin builds collagen. One of them cannot be dissolved.
Read the guide →Immediate Volume And The Collagen That Follows
A biostimulator gives some volume at once and more over months. Judging it on the day of treatment misreads it in both directions.
Read the guide →What Collagen Stimulation Feels Like Over The First Months
Firmness, tenderness and gradual change are what patients notice. Knowing when each is expected to settle keeps the weeks afterwards manageable.
Read the guide →Diluted And Spread, Or Placed Precisely
How a material is distributed decides much of the result. Diffuse placement and precise placement suit different problems.
Read the guide →Nodules After PCL Injections: Why They Form
Nodules are a recognised risk of polycaprolactone, they can appear months later, and they cannot be dissolved away.
Read the guide →How Often PCL And HA Filler Are Repeated
One material asks you to return on a calendar and the other asks you to accept a result you cannot revise. Neither is a stepping stone to the other.
Read the guide →Decide what happens if you dislike the result
Arrange an assessment. We will establish whether what has changed is volume or position, explain what each material leaves in the tissue and what can be done if it is wrong, and say plainly if neither is right for you.
Frequently asked questions
Can polycaprolactone be dissolved if I do not like the result?
No. There is no dissolving agent for it, and that is the most important practical difference between the two materials on this site. An uneven area, an over-treated region or a nodule is managed, watched, or in some cases removed surgically. Hyaluronic acid filler can be dissolved with an enzyme, though not always completely and not without risks of its own. If the possibility of an exit matters to you, that is a reason to choose the dissolvable material.
Which one works faster?
Hyaluronic acid filler, by a wide margin, because the volume it adds is there once the swelling settles. Polycaprolactone has some volume immediately and continues to develop over months as the skin builds collagen around the scaffold. Judging a biostimulator at two weeks means judging the wrong stage, and judging a hyaluronic acid filler at six months means looking at a result that is already fading.
Does the biostimulator last longer?
Usually, and not by an amount anyone can promise for you. The material remains in the tissue and the collagen built around it persists, so the change commonly fades slowly rather than ending. How long that is depends on the individual, the area and how the skin responds. What lasts longer is also what cannot be undone, and those two facts belong in the same sentence.
Are nodules common after polycaprolactone?
They are a recognised risk rather than a rarity, and they can appear months after treatment rather than immediately. They are associated with how superficially the material is placed, with how much is used in one area, and with technique. They are assessed by examination and sometimes imaging, and the options are observation, treatment of the area, or in some cases surgical removal. They cannot be dissolved.
What if neither injectable is right for me?
That is a common and legitimate outcome. Where the dominant change is descent, neither material repositions anything and the honest answer is a surgical assessment. Where it is skin quality, pigment or sun damage, neither treats it. Where volume has been lost across the whole face rather than in one place, the question is a different one and deserves to be asked before a course of injections is planned.
Who reviews the medical content on this site?
Every guide is medically reviewed by Ke He, MD, head of skin and laser aesthetics at Chongqing West District Hospital, and the review date appears on each article. The surgical view of volume loss and descent is represented on the reviewing team, so the injectable is not described only by the person who performs it. The site's own limits are set out in the health disclaimer.
Part of Injectables — 18 sites on this topic